Design and Baseline Data from Hephaistos Study Evaluating Efficacy and Safety of Early Initiation of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients

被引：0
|
作者：
Nashan, Bjorn [1 ]
Schemmer, Peter [1 ]
Braun, Felix [1 ]
Dworak, Markus [1 ]
Wimmer, Peter [1 ]
Schlitt, Hans [1 ]
机构：
[1] Hephaistos Study Grp, Nurnberg, Germany
来源：
TRANSPLANTATION | 2015年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-270
引用
收藏
页码：214 / 215
页数：2
相关论文
共 50 条
  • [31] Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fung, J.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Koneru, B.
    Huang, M. A.
    Chapman, W. C.
    Foltys, D.
    Witte, S.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (11) : 3008 - 3020
  • [32] TRANSFORM STUDY TO EVALUATE THE EFFECT OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITORS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: BASELINE DATA
    Arns, W.
    Weithofer, P.
    Witzke, O.
    Habicht, A.
    Banas, B.
    Renders, L.
    Rath, T.
    Lehner, F.
    Bartels, M.
    Von der Giet, M.
    Sommerer, C.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 25 - 25
  • [33] Design of a Randomized Study Aimed To Evaluate the Efficacy and Safety of Everolimus with Reduced Exposure Tacrolimus Versus Standard Tacrolimus in Living Donor Liver Transplant Recipients.
    Song, G. W.
    Chen, C. L.
    Lee, W. C.
    Joh, J. W.
    Levy, G.
    Pomfret, E.
    Lopez, P. M.
    Guido, J.
    Hexham, J. M.
    Uemoto, S.
    Suh, K. S.
    LIVER TRANSPLANTATION, 2013, 19 : S155 - S155
  • [34] Everolimus with Reduced Tacrolimus Exposure Versus Standard Tacrolimus in Hepatitis C Virus Positive De Novo Liver Transplant Recipients.
    Saliba, F.
    De Simone, P.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fung, J.
    Fischer, L.
    Huang, M. A.
    Wang, Y.
    Sips, C.
    Lopez, P.
    Nevens, F.
    LIVER TRANSPLANTATION, 2012, 18 : S98 - S98
  • [35] Everolimus with Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplant Recipients: Efficacy and Safety Outcomes from the TRANSFORM Study.
    Chadban, S.
    Mulgaonkar, S.
    Pascual, J.
    Tedesco, H.
    Berger, S.
    Qazi, Y.
    Legendre, C.
    Basic-Jukic, N.
    Bernhardt, P.
    Vincenti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 475 - 475
  • [36] Efficacy and Safety of Everolimus with Reduced-Dose Calcineurin Inhibitor in De Novo Kidney Transplant Recipients: Results from the TRANSFORM Study
    Pascual, Julio
    Chadban, Steve
    Tedesco, Helio
    Berger, Stefan
    Qazi, Yasir
    Cruzado, Josep M.
    Bernhardt, Peter
    Legendre, Christophe
    Kim, Myoung Soo
    Vincenti, Flavio
    TRANSPLANTATION, 2018, 102 : S367 - S368
  • [37] 12 MONTHS SAFETY AND EFFICACY DATA FROM ATHENA STUDY ON EVEROLIMUS-BASED VS TACROLIMUS-MPA REGIMEN IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Kamar, N.
    Merville, P.
    Suwelack, B.
    Sommerer, C.
    Dragun, D.
    Hauser, I. A.
    Schenker, P.
    Witzke, O.
    Hugo, C.
    Junge, M.
    Thaiss, F.
    Nashan, B.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 25 - 25
  • [38] TRANSFORM: A NOVEL STUDY TO EVALUATE THE EFFECT OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITORS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: BASELINE DATA
    Pascual, Julio
    TRANSPLANT INTERNATIONAL, 2015, 28 : 442 - 442
  • [39] Renal Function with Everolimus and Reduced Tacrolimus in De Novo Liver Transplant Recipients: 12 Month Results of the H2304 Study
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Foltys, D.
    Koneru, B.
    Wang, Y.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    LIVER TRANSPLANTATION, 2012, 18 : S85 - S86
  • [40] Efficacy and Safety of Everolimus with Reduced-Exposure Tacrolimus and Corticosteroid Withdrawal in De Novo Pediatric Renal Transplant Recipients: 12-Month Results from the CRADLE Study
    Ettenger, R.
    Tonshoff, B.
    Tedesco, H.
    Dello Strologo, L.
    Marks, S.
    Pape, L.
    Martzloff, E.
    Rauer, B.
    Ng, J.
    Lopez, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 407 - 408
12345